Clinical Trials Browser

Interventional × Acute Lung Injury × Inhalation × Clear all

NCT07558538 2026-04-30

Clinical Trial of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress Syndrome

Phase EARLY_PHASE1 Not yet recruiting

Lymphoma, Follicular, Acute Lung Injury